Stijn G. Krol
Leiden, ZH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Patient selection for proton therapy in lung cancer: Nationwide external validation and model update of a prognostic model for 2-year mortality including mean heart dose.
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: January 06, 2025
Effectiveness of the Assessment of Burden of Chronic Conditions (ABCC)-tool in patients with asthma, COPD, type 2 diabetes mellitus, and heart failure: A pragmatic clustered quasi-experimental study in the Netherlands.
Journal: The European journal of general practice
Published: May 13, 2024
A phase II study on the neo-adjuvant combination of pazopanib and radiotherapy in patients with high-risk, localized soft tissue sarcoma.
Journal: Acta oncologica (Stockholm, Sweden)
Published: September 23, 2021
The Influence of Personalised Sarcoma Care (PERSARC) Prediction Modelling on Clinical Decision Making in a Multidisciplinary Setting.
Journal: Sarcoma
Published: September 21, 2020
Primary sarcoma of the heart: case report and literature review.
Journal: Journal of cardiothoracic surgery
Published: January 28, 2020
Radiation Therapy as Sole Management for Solitary Fibrous Tumors (SFT): A Retrospective Study From the Global SFT Initiative in Collaboration With the Sarcoma Patients EuroNet.
Journal: International journal of radiation oncology, biology, physics
Published: December 21, 2017
In Reply to Güngör et al.
Journal: International journal of radiation oncology, biology, physics
Published: December 18, 2017
Local Protocol Variations for Image Guided Radiation Therapy in the Multicenter Dutch Hypofractionation (HYPRO) Trial: Impact of Rectal Balloon and MRI Delineation on Anorectal Dose and Gastrointestinal Toxicity Levels.
Journal: International journal of radiation oncology, biology, physics
Published: April 10, 2017
Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: February 29, 2016
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): late toxicity results from a randomised, non-inferiority, phase 3 trial.
Journal: The Lancet. Oncology
Published: October 29, 2015
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial.
Journal: The Lancet. Oncology
Published: February 07, 2015
Impact of cardiovascular counseling and screening in Hodgkin lymphoma survivors.
Journal: International journal of radiation oncology, biology, physics
Published: January 30, 2014
Showing 1-12 of 12
Last Updated: 09/26/2026